Development and validation of a predictive nomogram for leptomeningeal metastasis risk in NSCLC brain metastases: role of tumor location, driver mutations, and stereotactic radiosurgery - Top-Institutions - MDSpire

Development and validation of a predictive nomogram for leptomeningeal metastasis risk in NSCLC brain metastases: role of tumor location, driver mutations, and stereotactic radiosurgery

  • By

  • Shoaib Bashir

  • Song Jian

  • Weiping Hong

  • Hui Wang

  • Mingyao Lai

  • Hanbo Lin

  • Qianwen Liang

  • Meng Xu

  • Linbo Cai

  • September 18, 2025

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Neuro-oncology
    • Thoracic Oncology
    • Radiation Oncology
    • Molecular Oncology

  • #2

    Dana-Farber Cancer Institute / Brigham and Women's Hospital
    Dana-Farber Cancer Institute / Brigham and Women's Hospital

    Boston, MA

    Key Differentiators

    • Thoracic Oncology
    • Neuro-oncology
    • Radiation Oncology
    • Genomic Medicine

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Neuro-oncology
    • Thoracic Oncology
    • Radiation Oncology
    • Clinical Research

  • #4

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Neuro-oncology
    • Thoracic Oncology
    • Molecular Oncology
    • Radiation Oncology

  • #5

    National Cancer Center Hospital
    National Cancer Center Hospital

    Tokyo, Tokyo Prefecture

    Key Differentiators

    • Thoracic Oncology
    • Neuro-oncology
    • Radiation Oncology
    • Molecular Genetics

Original Source(s)

Development and validation of a predictive nomogram for leptomeningeal metastasis risk in NSCLC brain metastases: role of tumor location, driver mutations, and stereotactic radiosurgery

  • by Shoaib Bashir, Song Jian, Weiping Hong, Hui Wang, Mingyao Lai, Hanbo Lin, Qianwen Liang, Meng Xu, Linbo Cai

  • September 18, 2025

Related Content

HHLA2 as an emerging immune checkpoint in lung cancer: linking EGFR signaling, macrophage polarization, and CD8+ T-cell metabolic suppression

Targeted therapy combined with local consolidative surgery for oligometastatic stage IVA lung adenocarcinoma with CCDC6-RET fusion: a case report

Case Report: Acute myeloid leukemia with mixed immunophenotypic features and TCF3::ZNF384 fusion in a pediatric patient with CNS involvement: a diagnostic and therapeutic challenge